Our study demonstrated that in both in vivo and in vitro models of ischemic stroke, the genetic knockout of MK5 in microglial cells inhibited HSP27 phosphorylation, increased IκB phosphorylation, enhanced IκB degradation, activated the NF‐κB signaling pathway, and promoted inflammation. Here, MAPKAPK5 is linked to ischemic stroke.